LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$399M |
| 2 |
Invesco QQQ Trust
QQQ
|
$259M |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$258M |
| 4 |
FT Vest Fund of Buffer ETFs
BUFR
|
$254M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$217M |
Top Sells
Sector Composition
| 1 | Technology | 6.91% |
| 2 | Financials | 3.18% |
| 3 | Healthcare | 2.78% |
| 4 | Consumer Discretionary | 2.66% |
| 5 | Industrials | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCT
4501
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $91.9K | ﹤0.01% |
8,573
| – | – |
|
4502
Sana Biotechnology
SANA
$752M
| $91.7K | ﹤0.01% |
22,475
+2,150
| +11% | +$8.77K |
|
|
VRN
4503
DELISTED
Veren
VRN
| $91.5K | ﹤0.01% |
13,200
-1,399
| -10% | -$9.7K |
|
4504
AST SpaceMobile
ASTS
$11.4B
| $91.4K | ﹤0.01% |
15,159
-1,400
| -8% | -$8.44K |
|
4505
Retractable Technologies
RVP
$23.7M
| $89.7K | ﹤0.01% |
80,801
-1,500
| -2% | -$1.67K |
|
4506
Big 5 Sporting Goods
BGFV
$32.8M
| $89.1K | ﹤0.01% |
14,054
-1,445
| -9% | -$9.16K |
|
|
HTZWW
4507
Hertz Global Holdings Warrants
HTZWW
$260M
| $89K | ﹤0.01% |
16,243
+3,063
| +23% | +$16.8K |
|
4508
Lineage Cell Therapeutics
LCTX
$279M
| $88.3K | ﹤0.01% |
81,014
-14,986
| -16% | -$16.3K |
|
|
SWZ
4509
Swiss Helvetia Fund
SWZ
$79.6M
| $88.2K | ﹤0.01% |
+10,756
| New | +$88.2K |
|
4510
The Honest Company
HNST
$446M
| $86.1K | ﹤0.01% |
26,091
-232
| -0.9% | -$766 |
|
4511
Galectin Therapeutics
GALT
$295M
| $86K | ﹤0.01% |
51,812
| – | – |
|
4512
Sphere 3D
ANY
$18.3M
| $85.5K | ﹤0.01% |
+25,753
| New | +$85.5K |
|
4513
Microvision
MVIS
$334M
| $85.4K | ﹤0.01% |
32,122
+4,025
| +14% | +$10.7K |
|
|
NKLA
4514
DELISTED
Nikola Corporation Common Stock
NKLA
| $84.1K | ﹤0.01% |
3,205
+462
| +17% | +$12.1K |
|
4515
TETRA Technologies
TTI
$625M
| $83.1K | ﹤0.01% |
18,386
+3,596
| +24% | +$16.3K |
|
4516
CorMedix
CRMD
$926M
| $82K | ﹤0.01% |
21,800
+1,000
| +5% | +$3.76K |
|
|
ACB
4517
Aurora Cannabis
ACB
$276M
| $81.8K | ﹤0.01% |
17,182
-769
| -4% | -$3.66K |
|
4518
Innoviz Technologies
INVZ
$317M
| $80.7K | ﹤0.01% |
31,916
+13,308
| +72% | +$33.7K |
|
4519
Outlook Therapeutics
OTLK
$41.5M
| $79.3K | ﹤0.01% |
10,060
+5,000
| +99% | +$39.4K |
|
4520
Xeris Biopharma Holdings
XERS
$1.27B
| $78.4K | ﹤0.01% |
+33,375
| New | +$78.4K |
|
|
IRD
4521
Opus Genetics, Inc. Common Stock
IRD
$76.1M
| $78.3K | ﹤0.01% |
26,009
-6,795
| -21% | -$20.5K |
|
4522
GoPro
GPRO
$236M
| $78.1K | ﹤0.01% |
22,503
+3,366
| +18% | +$11.7K |
|
|
TSI
4523
TCW Strategic Income Fund
TSI
$238M
| $77.9K | ﹤0.01% |
16,962
-4,379
| -21% | -$20.1K |
|
4524
Oxford Square Capital
OXSQ
$172M
| $77.6K | ﹤0.01% |
27,136
-1,596
| -6% | -$4.57K |
|
|
DM
4525
DELISTED
Desktop Metal, Inc.
DM
| $77.6K | ﹤0.01% |
10,330
+2,646
| +34% | +$19.9K |
|